Sunday, June 29, 2025
Google search engine
HomeTechnologyRoboticsDistalmotion makes its first multirobot sale within the U.S.

Distalmotion makes its first multirobot sale within the U.S.



The Dexter surgical robotic. | Supply: Distalmotion

Distalmotion has made its first sale of a number of surgical robots within the U.S. AdventHealth, which operates 50 hospitals in 9 states, has chosen Distalmotion’s DEXTER system to assist the expansion of minimally invasive procedures. It has already accomplished its first instances with the system.

“We’re excited to have accomplished our first instances with DEXTER as we deliver robotic surgical procedure to our outpatient division,” mentioned Dr. Carlos Ortiz-Ortiz M.D., FACS, basic surgeon at AdventHealth Celebration. “As we develop our capabilities, we’re targeted on options that align with our objectives for flexibility and effectivity.”

DEXTER is designed to simplify operations and widen entry to robotic surgical procedure worldwide, in response to Distalmotion. The Lausanne, Switzerland-based firm provides its expertise to hospital outpatient departments (HOPDs) and ambulatory surgical facilities (ASCs). Distalmotion, which has U.S. workplaces in Cleveland, mentioned DEXTER is commercially out there within the U.S. and Europe.

DEXTER designed for flexibility

Demand for surgical robotics continues to rise, and extra high-volume soft-tissue procedures—reminiscent of inguinal hernia restore and cholecystectomy—are transferring into outpatient settings. In response, healthcare amenities are in search of options that match their medical and operational wants. Nonetheless, their concentrate on effectivity and affected person expertise makes current soft-tissue robots impractical because of dimension, operational complexity, and prices, mentioned Distalmotion.

The corporate mentioned it designed DEXTER to be cell and sufficiently small to be simply moved between working rooms (ORs), arrange shortly, and built-in into current procedures. It might cut back turnover time, maximize throughput, and improve the variety of sufferers who profit from minimally invasive care, mentioned Distalmotion.

The corporate claimed that DEXTER is the one system out there within the U.S. and European markets with each a sterile console and absolutely open structure. The sterile console permits surgeons to carry out bedside duties after which instantly return to operation with no change in sterility or redocking of the robotic.

The console retains the surgeon near the affected person, helps transitions between laparoscopic and robotic strategies as desired, and enhances communication with OR groups, mentioned Distalmotion.

DEXTER’s open structure helps the usage of most popular devices and OR applied sciences which might be already out there within the facility, minimizing the necessity to to buy expensive new applied sciences. DEXTER comes with a collection of absolutely wristed single-use robotic devices to reinforce dexterity and precision.

The structure permits compatibility with current and future OR applied sciences, together with visualization techniques and superior units, for cost-effective provide chain operations. Collectively, these options give surgeons the power to make use of workflows they consider are finest for every affected person.

“This multi-system sale underscores how well being techniques are in search of extra versatile options that deliver the advantages of robotics to ORs throughout their websites of care,” acknowledged Greg Roche, CEO of Distalmotion. “DEXTER is designed to fulfill the realities of outpatient surgical procedure, with out compromising current practices.”

Distalmotion builds momentum in U.S. enlargement

The DEXTER Robotic Surgical procedure System is at present licensed just for use in inguinal hernia restore and cholecystectomy for adults 22 years previous and older within the U.S. In Europe, the robotic is meant to help within the correct management of laparoscopic surgical devices throughout urologic, basic, and gynecologic procedures.

DEXTER has been concerned in additional than 2,000 procedures accomplished globally throughout basic, gynecological, and urological specialties. Distalmotion mentioned stays targeted on making robotic surgical procedure extra accessible throughout extra websites of care globally.

In March, the corporate mentioned it had accomplished its first U.S. sale and supply of DEXTER to Memorial Hermann Well being System. The built-in system serves Southeast Texas and the higher Houston group with greater than 270 care supply websites, together with 17 hospitals.

Later that month, it introduced that Northtowns ASC had chosen DEXTER for robotic outpatient surgical procedures.

This yr, Distalmotion additionally accomplished two research, the NEST research (NCT06473688) targeted on cholecystectomy and the HYPER research (NCT06473675) pertaining to benign hysterectomy. Distalmotion has additionally initiated its sacrocolpopexy medical research, with the primary affected person enrolled in Q1 2025. The corporate mentioned these research will assist it higher meet the evolving wants of healthcare suppliers.

Editor’s notice: This text is syndicated The Robotic Report sibling website MassDevice.



Supply hyperlink

RELATED ARTICLES

LEAVE A REPLY

Please enter your comment!
Please enter your name here

- Advertisment -
Google search engine

Most Popular

Recent Comments